Rhian Linney, Associate Communications Director at Galapagos, UK and Ireland, tells Pharmafocus about the significance of the patient voice in autoimmune conditions, focusing on rehumatoid arthritis
Features, Mar 6, 2023
ScotBio has announced "promising initial results" from its attempt to extract a cure for the common cold from algae
UK News, Mar 6, 2023
Nikunj Desai, head of supply chain at ACG, explores how supply chains can be made more secure and the impacts this may have on the pharma industry
Industry Insights, Mar 6, 2023
NICE has recommended eight new digital therapies to be used by the NHS for the treatment of mental health disorders
UK News, Mar 6, 2023
Pharmafocus talks to Scott Curley about the risks of CVD and the imporance of getting the right treatment at the right time
Interviews, Mar 6, 2023
Pharmafocus shares five interesting facts about CVD
Industry Facts, Mar 6, 2023
Pharmafocus sat down with Joaquin Mould, Global HEOR & Value Strategy Director, Seqirus, to get to the heart of what invaluable insights RWE can give us on vaccine efficacy
Industry Insights, Sep 1, 2022
Why do such a significant amount of vaccines in the UK come from Flanders and what does this mean in the ongoing COVID-19 pandemic?
Industry Insights, Dec 1, 2022
The Follicular Lymphoma Foundation tells Pharmafocus about new research being conducted into blood cancer follicular lymphoma and their new research grant programme
Industry Insights, Dec 1, 2022
NICE has recommended eight new digital therapies to be used by the NHS for the treatment of mental health disorders
UK News, Mar 6, 2023
Eli Lilly and AbbVie both announce that they will leave VPAS, causing concern that NHS patients may not receive breakthrough drug treatments
UK News, Mar 6, 2023
Merck has been planning a $1.3bn research hub in london for the last six years, but this will finally begin construction in April
UK News, Mar 6, 2023
The ECMC in Cambridge is one of a handful of organisations to receive a share of £47.5 funding over the next five years
UK News, Mar 6, 2023
The NHS will soon begin offering artificial pancreas to type 1 diabetes patients to help them manage their condition more effectively
UK News, Mar 6, 2023
ScotBio has announced "promising initial results" from its attempt to extract a cure for the common cold from algae
UK News, Mar 6, 2023
Researchers at UCL have begun looking into the impacts of ambroxol as a treatment for Parkinson's disease
UK News, Mar 6, 2023
Unison general secretary Christina McAnea said that the ongoing ambulance strikes will continue to go ahead without a “very firm commitment” on pay, as the Government has “adamantly refused” to engage in a “proper discussion” about pay rises.
UK News, Feb 1, 2023
GlaxoSmithKline has chosen to establish its new headquarters in London’s West End, on the corner of New Oxford Street and Earnshaw Street in the Capital’s centre. The new hub is expected to open in 2024.
UK News, Feb 1, 2023
UK-based point-of-care diagnostics company LumiraDx has been given $14m in grants from the Bill & Melinda Gates Foundation to support the ongoing development of its point-of-care molecular tuberculosis (TB) test system.
UK News, Feb 1, 2023
Japan-based Sosei Heptares announced that it has joined forces with UK global biopharma company Eli Lilly to discover, develop and commercialise small molecules that modulate novel G protein-coupled receptor (GPCR) targets associated with diabetes and metabolic diseases.
UK News, Feb 1, 2023
German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU), which will accelerate clinical trials of personalised mRNA immunotherapies. It is hoped this acceleration will lead to up to 10,000 patients receiving such therapies by the end of 2030.
UK News, Feb 1, 2023
Molnupiravir, made by Merck, Sharp and Dohme (MSD), has been found to reduce the recovery time of COVID-19 patients, however it did not decrease mortality rates or hospital admissions.
UK News, Feb 1, 2023
UK-based GSK has announced a partnership with American company Wave Life Sciences, valued at up to $3.3bn. The partnership will allow GSK to use Wave’s PRISM technology – an oligonucleotide platform that combines chemistry with multiple therapeutic modalities, including editing, splicing and silencing.
UK News, Feb 1, 2023
Upstaza given marketing authorisation for AADC deficiency
UK News, Dec 1, 2022
A world-first trial is expected to evaluate the efficacy of stem cell transplants for MS patients
UK News, Dec 1, 2022
Bharat Biotech has recently launched its new intranasal COVID-19 vaccine iNCOVACC
Global, Mar 6, 2023
The TGA has announced its approval of the use of psychedelics to treat certain mental health conditions
Global, Mar 6, 2023
A strongly drug-resistant bacterium has been found in various brands of artificial tears eye drops, infecting 55 people throughout 12 states
Global, Mar 6, 2023
A subsidiary of J&J has lost a bankruptcy petition aiming to transfer thousands of legal claims against the subsidiary related to the claim that its talcum powder causes cancer
Global, Mar 6, 2023
WHO has issued a 'call to action' to all member states in order to try to prevent, detect and respond to incidences of illegitimate medical products
Global, Mar 6, 2023
SU2C has announced four teams focusing on increasing diversity in early phase cancer clinical trials
Global, Mar 6, 2023
A parliamentary committee in the Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as it has sold contaminated medicine that is believed to be linked to the deaths of at least 70 children in the Gambia.
Global, Feb 1, 2023
The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)- unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours.
Global, Feb 1, 2023
Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company developing an investigational drug to treat human immunodeficiency virus (HIV).
Global, Feb 1, 2023
Following new rules from the FDA under the Biden administration, patients can now obtain the abortion pill mifepristone from retail pharmacies, rather than having to collect the medication in person from their healthcare provider. A prescription for the drug is still required, however this can now be filled at an instore pharmacy or by mail order.
Global, Feb 1, 2023
The FDA has approved new and contraversial Alzheimer’s drug, lecanemab
Global, Feb 1, 2023
The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high point, which has led to multiple manufacturers reporting shortages of a flu drug, Tamiflu.
Global, Feb 1, 2023
BioNTech has announced the start of its new first-in-human phase 1 trial for BNT165b1, a candidate from its programme that aims to develop a multi-antigen malaria vaccine.
Global, Feb 1, 2023
Merck has donated ebola vaccines to be tested on a resistant strain of the virus
Global, Dec 1, 2022
Eisai and Biogen's new Alzheimer's drug, lecanemab, appears to slow disease progression but remains controversial.
Global, Dec 1, 2022
Pulmonx, a US-based medical technology company, has secured approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its Zephyr Endobronchial Valve, used to treat patients with severe chronic obstructive pulmonary disease (COPD) or emphysema.
Global, Dec 1, 2022
Following the increase in respiratory infections, the continuing cost of living crisis and the Russia-Ukraine conflict, Europe is planning countermeasures for further antibiotic shortages
Europe, Mar 6, 2023
AstraZeneca has announced plans to open a new facility in Ireland, previously planned for northwest England
Europe, Mar 6, 2023
Genoscience Pharma has received FDA ODD for its hepatocellular carcinoma drug
Europe, Mar 6, 2023
Regeneron Pharmaceuticals and Sanofi have announced that the European Commission (EC) has expanded the marketing authorisation for Dupixent® (dupilumab) in the European Union to treat adults with moderate-to-severe prurigo nodularis who are candidates for systemic therapy.
Europe, Feb 1, 2023
ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system for outsourced pharmaceutical manufacturing.
Europe, Feb 1, 2023
Recently, AstraZeneca announced two drug approvals in the European Union (EU), the first being Imfinzi’s approval for the treatment of biliary tract cancer, and the latter being Lynparza for prostate cancer.
Europe, Feb 1, 2023
Polish clinical stage biotechnology company Molecure has announced its third quarter results for the period ending 30 September 2022. Its press release also mentions its plans for its R&D day in December, and its strategies and preparations for various phase 1 and 2 clinical trials.
Europe, Dec 1, 2022
Karyopharm Therapeutics and the Menarini Group’s Nexpovio (selinexor) has been granted orphan medicinal product designation by the European Commission (EC). The drug is intended to treat myelofibrosis (MF), a rare kind of bone marrow cancer.
Europe, Dec 1, 2022
AstraZeneca has announced that three of its drugs have been recommended for EU approval. The three drugs are: Imfinzi, Enhertu and Lynparza, all of which can be used to treat different cancers.
Europe, Dec 1, 2022
A team of scientists at the Technical University of Denmark have genetically engineered yeast to recreate vinblastine, an anti-cancer drug which was in short supply between 2019-2021. It is hoped this breakthrough will pave the way to creating more synthetic anti-cancer drugs.
Europe, Oct 27, 2022
The Swiss pharma group has agreed to buy Seattle-based biotech Good Therapeutics and its preclinical-stage PD-1 regulated IL-2 receptor agonist programme for $250 million upfront, with undisclosed milestone payments on offer tied to development, regulatory, and commercial objectives.
Europe, Oct 27, 2022
A team of scientists from the University of Copenhagen, Denmark have designed a sticky tape skin test which could help predict if young babies are likely to develop bad eczema, according to BBC News.
Europe, Oct 27, 2022
EMA responds to monkeypox public health emergency, EMA recommends treatment for multiple myeloma patients with limited options
Europe, Sep 1, 2022
Ukraine’s health emergency is worsening, WHO have shared as the conflict with Russia continues, and staff face burnout and increased shelling. So far, there have been 434 attacks on healthcare facilities in the country.
Europe, Sep 1, 2022
Lenvatinib is indicated or treatment for adults with advanced renal cell carcinoma
Europe, Sep 1, 2022
The EMA’s Medicines Shortages Steering Group (MSSG) has now adopted the list of critical medicines for the COVID-19 public health emergency. The medicines included in the list are authorised for COVID-19, and their supply and demand will be closely monitored, aiming to identify and manage potential or actual shortages.
Europe, Aug 4, 2022
Welcome to the March 2023 issue of Pharmafocus! This issue covers the latest pharma news, and features articles on CVD, supply chains and the importance of the patient voice.
Welcome to the January/February edition of Pharmafocus! This edition includes the biggest news from new drug approvals in the US, EU, and elsewhere, to the FDA's new regulations around medication abortions, as well as an article from the expert panel of the new Let's Talk Prostate Cancer initiative.
The December 2022 edition of Pharmafocus. The latest updates including: UK, EU and global Pharma news, Follicular Lymphoma, vaccines and R&D
Monkeypox, health equity, precision medicine in mental health, Professor Reilke Allan on rheumatoid arthritis, vaccines and all the latest news and analysis of the pharmaceutical industry
Sign up to our newsletters and digital magazines
Browse older editions
Giuseppe Accogli is hired as Chiesi Farmaceutici's new CEO
Appointments, Mar 6, 2023
Dr Mark Chadwick is appointed to Ingenza's strategic business advisor
Appointments, Mar 6, 2023
Pia Baumann is appointed to Medivir AB's chief medical officer
Appointments, Mar 6, 2023
Vishal Kapoor joins Jasper Therapeutics' board of directors
Appointments, Mar 6, 2023
Elligo Health appoints Dawn Saura as chief operating officer
Appointments, Feb 1, 2023
Maha Radhakrishnan is appointed to board member at Minovia Therapeutics
Appointments, Feb 1, 2023
Priya Singhal appointed to executive vice president and head of development at Biogen
Appointments, Feb 1, 2023
Elaine Sun joins the board of directors at Asher Bio
Appointments, Feb 1, 2023
Peter Williams is appointed to general manager at Incyte Biosciences UK
Appointments, Dec 1, 2022
Dr Frank Mathias appointed to CEO of Oxford Biomedica
Appointments, Dec 1, 2022
Scott Curley appointed general manager at Amarin
Appointments, Dec 1, 2022
Norwegian immuneoncology company Lytix has announced the appointment of Stephen Worsley as Chief Business Officer.
Appointments, Oct 27, 2022
NervGen is a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage. They have appointed Matvey Lukashev, PhD, as the company’s Vice President of Research and Preclinical Development.
Appointments, Oct 27, 2022
Dr Jerry McMahon has been appointed CEO for STORM Therapeutics as it transitions into a clinical-stage company with a pipeline of products targeting RNA modifying enzymes.
Appointments, Oct 27, 2022
Valeo Pharma is a pharmaceutical company dedicated to the commercialisation of innovative prescription products in Canada, with a focus on respirology/allergy, opthamology, and other products.
Appointments, Oct 27, 2022
Pliant Therapeutics has appointed Katharine Knobil to its Board of Directors.
Appointments, Oct 27, 2022
Pharmaceutical Industry news, analysis and insights
